What is the role of medications in the treatment of inferior vena cava thrombosis (IVCT)?

Updated: Jun 12, 2018
  • Author: Luis G Fernandez, MD, FACS, FASAS, FCCP, FCCM, FICS, KHS, KCOEG; Chief Editor: John Geibel, MD, DSc, MSc, AGAF  more...
  • Print

The goals of pharmacotherapy for inferior vena caval thrombosis (IVCT) and deep vein thrombosis (DVT) are to reduce morbidity, to prevent the postthrombotic syndrome (PTS), and to prevent pulmonary embolism (PE), all with minimal adverse effects and cost. The main agent classes include anticoagulants and thrombolytics.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!